Page results
-
Patient information for patients undergoing Image Rehearsal Therapy (IRT).
-
The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients at highest risk in the community from the NCL sector. These treatments involve intravenous infustion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test.
-
Anaemia is a condition in which the body has fewer red blood cells, or have less haemoglobin in the red blood cells, than normal. Patients who may have anaemia can be referred to general haematology by GPs and hospital doctors.
-
UCLH treats a range of red cell blood disorders and anaemias.
-
This page is for patients who are receiving radiotherapy to the bladder.
-
This page is designed for patients scheduled to attend our department. It outlines the various tests that may be conducted during your appointment.
-
This page is designed for patients scheduled to attend the Adult diagnostic audiology department. It outlines the various tests that may be conducted during your appointment.
-
UCLH provides an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia. We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
File results
-
FOI/2023/0199 - Patients diagnosed with Cauda Equina Syndrome
-
FOI/2023/0195 - Patient level costing system and integrated data platform
-
FOI/2023/0192 - Non emergency patient transport - NEPTS and taxi procurement
-
FOI/2023/0187 - Treatment for urothelial and colorectal cancer
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0180 - Treatment guidelines for chronic kidney disease/ diabetic kidney disease
-
FOI/2023/0175 - Treatment for Myelofibrosis
-
FOI/2023/0139 - Meningitis and Encephalitis guidelines/ pathway
-
FOI/2023/0143 - Immunoassay Analysers at Trust
-
FOI/2023/0142 - Treatment of breast cancer